Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241630 | 0.94 | CAMK2A (0.58) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL241629 | 0.94 | GPR84 (0.60) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL589199 | 0.92 | GPR84 (0.64) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL5448040 | 0.91 | GPR84 (0.56) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL15760620 | 0.91 | CAMK2A (0.54) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL3783332 | 0.90 | GPR84 (0.61) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL25240814 | 0.89 | GPR84 (0.60) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL28959802 | 0.89 | GPR84 (0.60) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL7513971 | 0.89 | GPR84 (0.54) | CAMK2AGPR84FFAR1FFAR4TSHR | |
| SCHEMBL208716 | 0.89 | GPR84 (0.60) | CAMK2AGPR84FFAR1FFAR4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287435-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | AGAIN BIO APS (DK) | 2023-09-14 | — | — | US | claimed |
| CN-114728871-A | Microorganisms and methods for reducing by-products | 基因组股份公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021086944-A1 | MICROORGANISMS AND METHODS FOR RECUCING BY-PRODUCTS | GENOMATICA, INC. (US) | 2021-05-06 | — | — | WO | claimed |
| CN-117980472-A | Formate dehydrogenase variants and methods of use | 基因组股份公司 | 2024-05-03 | — | — | CN | disclosed |
| EP-4334379-A1 | PACKAGING MATERIAL HAVING ANTI-MICROBIAL PROPERTIES | SOREMARTEC S.A. (LU) | 2024-03-13 | — | — | EP | disclosed |
| US-20230287435-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | AGAIN BIO APS (DK) | 2023-09-14 | — | — | US | disclosed |
| CN-115536935-A | Plastic alloy, plastic product and preparation method of plastic alloy | 印尼永吉纸业, 巴拉望厂 | 2022-12-30 | — | — | CN | disclosed |
| US-20220395456-A1 | CONTRACEPTIVE MEDICAL DEVICES | POLY-MED, INC. | 2022-12-15 | — | — | US | disclosed |
| CN-114901815-A | Microorganisms and methods for increasing cofactors | 基因组股份公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114728871-A | Microorganisms and methods for reducing by-products | 基因组股份公司 | 2022-07-08 | — | — | CN | disclosed |
| US-11111202-B2 | Production of salts of 4-hydroxybutyrate using biobased raw materials | CJ CHEILJEDANG CORPORATION (KR) | 2021-09-07 | — | — | US | disclosed |
| CN-107090424-A | Utilize the method and organism of synthesis gas or other gaseous carbon sources and methanol | 基因组股份公司 | 2017-08-25 | — | — | CN | disclosed |
| CN-107075464-A | The recombinant microorganism of alkene is produced from acetyl-COA | 环球生物能源公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-107014939-A | The method that the switching combination of ion exclusion ion exchange column determines the γ hydroxybutyric acids in urine | 南京市公安局刑事侦查局 | 2017-08-04 | — | — | CN | disclosed |
| CN-101978042-B | Methods and organisms for utilizing syngas or other gaseous carbon sources and methanol | 基因组股份公司 | 2017-03-08 | — | — | CN | disclosed |
| US-20160068463-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | CJ CHEILJEDANG CORPORATION (KR) | 2016-03-10 | — | — | US | disclosed |
| EP-2961738-A2 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | Metabolix, Inc. (US) | 2016-01-06 | — | — | EP | disclosed |
| CN-104321434-A | Methods for biosynthesizing 1,3butadiene | INVISTA TECH SARL | 2015-01-28 | — | — | CN | disclosed |
| WO-2014078014-A2 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | METABOLIX, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| EP-0632124-B1 | Synthetic lubricating oil and working fluid composition for refrigerating machine | NOF CORP (JP) | 1998-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160068463-A1 | PRODUCTION OF SALTS OF 4-HYDROXYBUTYRATE USING BIOBASED RAW MATERIALS | HBB, HMBS, AGL | CAMK2A 2882/4885GPR84 1840/4885FFAR1 199/4885 |
| US-11111202-B2 | Production of salts of 4-hydroxybutyrate using biobased raw materials | HBB, HMBS, AGL | CAMK2A 2882/4885GPR84 1840/4885FFAR1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.